---
company: Radiopharm Theranostics Ltd
ticker: RADX
form: 6-K
filed: 2026-09-11
accession: 0001213900-26-098976
source: https://www.sec.gov/Archives/edgar/data/1949257/000121390026098976/
---

# Radiopharm Theranostics (RADX) earnings release, September 11, 2026

Radiopharm Theranostics Ltd (RADX) · Form 6-K · Filed 2026-09-11 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1949257/000121390026098976/)

Exhibit

99.1

Results of General Meeting

Sydney,

Australia – Friday, 11 September 2026 – Radiopharm Theranostics Limited

(ASX: RAD; Nasdaq: RADX) advises that all resolutions considered at the General Meeting held today were carried by poll.

In accordance with ASX Listing Rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.

Amritha

Sushil

Joint

Company Secretary

Radiopharm

Theranostics Limited

Suite

1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia

ABN:

57 647 877 889

In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.²³
